Scientists Spot New Clues to HIV-Linked
THURSDAY, Oct. 6 (HealthDay News) -- Researchers have identified
two genetically distinct types of HIV in the cerebrospinal fluid
(CSF) of patients with HIV-associated dementia.
The discovery may help explain why the risk of developing
neurological difficulties increases as AIDS patients live longer,
and may also help predict which patients are at greatest risk for
the problem, according to the U.S. scientists.
They said the two newly-identified HIV types aren't being
detected in HIV that circulates in a patient's blood, and one type
may be present cerebrospinal fluid years before the onset of
The fact that the two HIV types can be detected in the CSF
indicates that they grow in the central nervous system, the
The finding might also help explain while highly active
antiretroviral therapy -- the drug "cocktails" that HIV-positive
patients take to stay healthy -- can help prevent some of the
neurological troubles associated with infection, but not all.
The study, which appears in the Oct. 6 issue of the journal
PLoS Pathogens, was led by researchers at the University of North Carolina at Chapel Hill School of Medicine.
Besides spotting the two types of HIV in cerebrospinal fluid,
the team also made another discovery: While HIV is known to infect
and replicate within immune system T-cells, one of the two HIV
types found in CSF does so in another immune cell, called
"This is the first time that anyone has demonstrated active replication of HIV virus in a cell type other than T- cells," study senior author Ronald Swanstrom, a professor of biochemistry and biophysics and director of the UNC Center for AIDS Research, noted in a university news release.
The finding could enhance scientists' understanding of why some
patients respond better than others to HIV treatment.
"We know that HIV in the blood disappears quickly when you go on therapy, and that's because the virus is growing in T-cells, which have a very short half-life," the amount of time it takes for the level of virus to drop by half, Swanstrom explained.
But half of the patients In the new study showed a much slower
rate of decay when it came to the amount of virus in their CSF.
"This is evidence the virus is actually being produced by a cell
with a longer half-life, and not a T-cell," Swanstrom
The next step is to determine how relevant all of this might be
to HIV-linked neurological issues.
"Is it bad to have these viruses around even if you don't get a diagnosis of dementia?" Swanstrom said. "And are they potentially causing cognitive damage that can be reversed with [treatment]?"
More research investigating those issues is planned, the team
The U.S. National Institute of Neurological Disorders and Stroke
has more about the
neurological complications of AIDS.
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.